DEPLOYDatabase

Company

Medicaroid

Japanese medical robotics company and joint venture of [Kawasaki Heavy Industries](/companies/kawasaki-heavy-industries) and Sysmex, developing the hinotori™…

Founded
2013
HQ
Kobe, Hyogo Prefecture, Japan

Models

1

Overview

Japanese medical robotics company and joint venture of Kawasaki Heavy Industries and Sysmex, developing the hinotori™ Surgical Robot System — Japan's first domestically manufactured robotic-assisted surgery platform. Medicaroid obtained Japanese regulatory approval in 2020, received CE mark under MDR in July 2026 for European market entry, and has expanded across Asia-Pacific with approvals in Singapore (2023), Malaysia (2024), and Vietnam (2026). Approximately 20,000 procedures have been performed globally with the hinotori system.

Verified record

Verified deployments
None on file
Active incidents
None on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

CEO

Koji Muneto (Board Director, CEO and President)

Chairman

Yasuhiko Hashimoto

Parent companies

Kawasaki Heavy Industries + Sysmex (joint venture)

Product

hinotori™ Surgical Robot System

Japan approval

2020 (first domestic manufacturer)

CE mark

July 2026 (under MDR)

Asia-Pacific approvals

Singapore (2023), Malaysia (2024), Vietnam (2026)

Procedures performed

~20,000 globally

Surgical specialties

Urology, general surgery, gynecology, thoracic surgery

Financial stage

Joint venture — funded by Kawasaki Heavy Industries and Sysmex

Current leadership (2)

Safety record

No incidents on record for Medicaroid.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Medicaroid in third-party press